CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Liver Education About Pain (LEAP) +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05128578
NCT05128578N/ACompleted

Improving Pain Management and Opioid Safety for Patients With Cirrhosis: Pilot Program

University of Pittsburgh·interventional·Posted Nov 22, 2021·Updated Dec 10, 2024

In Brief

A clinical study evaluating Liver Education About Pain (LEAP) and Usual Care for Cirrhosis, Liver. Completed, enrolled 30 participants across 1 site.

Detailed Summary

This project aims to test a behavioral intervention in patients with liver cirrhosis and chronic pain and teach self pain-management skills.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20222023202420252026
First PostedNov 22, 2021
Enrollment StartMar 14, 2022
Primary CompletionOct 21, 2023
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 4.6 years ago

Interventions

Liver Education About Pain (LEAP)behavioral

LEAP is a modular 12-week pain self-management intervention with 6 individual sessions and 6 optional group sessions. Individual sessions serve the purpose of individualizing the program to the needs of the patients. Group sessions allow participants to practice skills, set goals with the group, seek social support, and learn together. The purpose of the LEAP program is to make pain better, help patients reach their personal goals (things that may be hard to do because of pain), and add to the care patients' medical team is providing.

Usual Carebehavioral

Patients can continue to use other pain management strategies ("usual care") in order to mimic real-life conditions.